4BIO Capital

Profile

4BIO Capital is a London-based venture capital firm focused exclusively on advanced therapies. They were founded with the aim of investing in companies developing innovative treatments in areas with significant unmet medical needs. The team's background includes leading scientists and experienced life science investors, together boasting over 250 scientific publications. A distinctive trait of 4BIO is their deep understanding and network within the advanced therapy sector.

4BIO Capital is concentrated on sectors such as cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. Their investment strategy targets early-stage companies with the potential to develop curative therapies. While the specific fund sizes and stages are not detailed, their focus indicates significant expertise in nurturing high-growth potential start-ups within the life sciences domain. They are also active in providing their insights and capital to guide burgeoning firms in the sector.

Among their notable investments are companies that stand out in the advanced therapies landscape, although the specifics of these portfolio companies are not listed on the provided site data. The firm is recognized for its comprehensive approach towards investing in transformative medical solutions and supporting their growth with both capital and strategic guidance.